199 related articles for article (PubMed ID: 23931497)
1. Intraocular (vitreoretinal) lymphoma following primary testicular lymphoma.
Grange LK; Jacobs-El N; Wiley HE; Kurup S; Chan CC; Sen HN
Can J Ophthalmol; 2013 Aug; 48(4):e95-7. PubMed ID: 23931497
[No Abstract] [Full Text] [Related]
2. Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
Pe'er J; Rowe JM; Frenkel S; Dann EJ
Am J Hematol; 2010 Aug; 85(8):631-3. PubMed ID: 20658596
[No Abstract] [Full Text] [Related]
3. Secondary Vitreoretinal Lymphoma Masquerading as Acute Retinal Necrosis.
Ryan ME; Shantha JG; Grossniklaus HE; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1048-50. PubMed ID: 26599249
[TBL] [Abstract][Full Text] [Related]
4. Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma.
Yeh S; Wilson DJ
Eye (Lond); 2010 Oct; 24(10):1625-7. PubMed ID: 20706284
[No Abstract] [Full Text] [Related]
5. Intraocular (vitreoretinal) lymphoma with renal, pelvic, and central nervous system lesions.
Bhatt N; Fox A; Chan CC; Roschewski M; Sen HN
Can J Ophthalmol; 2014 Aug; 49(4):e104-6. PubMed ID: 25103663
[No Abstract] [Full Text] [Related]
6. Diagnostic criteria for primary ocular lymphoma.
Arcinue CA; Hochberg F; Neumann R; Foster CS
Ophthalmology; 2013 Mar; 120(3):646-646.e2. PubMed ID: 23714608
[No Abstract] [Full Text] [Related]
7. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma.
Riemens A; Missotten T; Baarsma S; Vidovic-Valentincic N; Novac-Andrejcic K; Erckens R; Kuijpers R; Lokhorst H; Rothova A
Acta Ophthalmol; 2014 Mar; 92(2):e159-60. PubMed ID: 23819861
[No Abstract] [Full Text] [Related]
8. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.
Larkin KL; Saboo US; Comer GM; Forooghian F; Mackensen F; Merrill P; Sen HN; Singh A; Essex RW; Lake S; Lim LL; Vasconcelos-Santos DV; Foster CS; Wilson DJ; Smith JR
Br J Ophthalmol; 2014 Jan; 98(1):99-103. PubMed ID: 24158837
[TBL] [Abstract][Full Text] [Related]
9. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
[TBL] [Abstract][Full Text] [Related]
11. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
12. Testicular lymphoma.
Thomas LC; Adonizio C; Filicko-O'Hara J; Golshayan AR; Costa LJ; Morris GJ
Semin Oncol; 2010 Dec; 37(6):549-54. PubMed ID: 21167372
[No Abstract] [Full Text] [Related]
13. Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.
Leskov I; Lyon AT; Jampol LM
JAMA Ophthalmol; 2019 Jul; 137(7):834-837. PubMed ID: 31046111
[TBL] [Abstract][Full Text] [Related]
14. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Conrad AL; Go RS
Eur J Haematol; 2009 Dec; 83(6):603-5. PubMed ID: 19682312
[TBL] [Abstract][Full Text] [Related]
15. Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years.
Aliferis K; Chan CC; Donati G; Baglivo E
Int Ophthalmol; 2008 Dec; 28(6):439-40. PubMed ID: 17985076
[No Abstract] [Full Text] [Related]
16. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
Kvopka M; Lake SR; Smith JR
Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
[TBL] [Abstract][Full Text] [Related]
17. Smudge in my vision.
Nwanyanwu KH; Lim JI
JAMA Ophthalmol; 2013 Dec; 131(12):1637-8. PubMed ID: 24337560
[No Abstract] [Full Text] [Related]
18. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Huang HC; Cheng AL; Lin CW; Kuo SH
Ann Hematol; 2013 Jul; 92(7):989-92. PubMed ID: 23242476
[No Abstract] [Full Text] [Related]
20. Use of intravitreal rituximab and methotrexate in vitreoretinal lymphoma.
Rahhal-Ortuño M; Udaondo-Mirete P; Fernández-Santodomingo AS; Díaz-Llopis M
Eur J Ophthalmol; 2022 Jan; 32(1):NP199-NP202. PubMed ID: 32985253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]